#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA884268	B	Inhibition of [3H]apomorphine binding to calf caudate membrane preparation (p4)		17		assay format	Scientific Literature
2.	ALA654452	B	Inhibition of [3H]spiroperidol binding to calf caudate membrane preparation (p4)		17		assay format	Scientific Literature
3.	ALA672894	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by po administration	Rattus norvegicus	3		organism-based format	Scientific Literature
4.	ALA672895	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by po administration; Inactive	Rattus norvegicus	2		organism-based format	Scientific Literature
5.	ALA672896	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; Inactive	Rattus norvegicus	8		organism-based format	Scientific Literature
6.	ALA672897	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested	Rattus norvegicus	1		organism-based format	Scientific Literature
7.	ALA668257	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; partial response at the highest dose tested	Rattus norvegicus	2		organism-based format	Scientific Literature
8.	ALA668258	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by po administration	Rattus norvegicus	4		organism-based format	Scientific Literature
9.	ALA668259	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by po administration; partial response at the highest dose tested	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA669500	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration	Rattus norvegicus	7		organism-based format	Scientific Literature
11.	ALA669501	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration; Inactive	Rattus norvegicus	2		organism-based format	Scientific Literature
12.	ALA669502	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested	Rattus norvegicus	3		organism-based format	Scientific Literature
13.	ALA669503	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by po administration	Rattus norvegicus	4		organism-based format	Scientific Literature
14.	ALA669504	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by po administration; partial response at the highest dose tested	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA669505	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration	Rattus norvegicus	7		organism-based format	Scientific Literature
16.	ALA669506	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration; Inactive	Rattus norvegicus	2		organism-based format	Scientific Literature
17.	ALA669507	F	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested	Rattus norvegicus	3		organism-based format	Scientific Literature
18.	ALA669517	F	Compound was evaluated for its ability to inhibit Striatal Dopamine Receptor in rat brain through radioreceptor assay carried out with agonist ligand.		5		tissue-based format	Scientific Literature
19.	ALA672973	B	Compound is tested for its ability to displace Di-Pr-5,6-ADTN at 0.25 umol/kg subcutaneous dose from rat striatal binding sites in vivo		1		organism-based format	Scientific Literature
20.	ALA672974	B	Ability to displace the DA receptor agonist DiPr-5,6-ADTN from rat striatal binding sites in vivo at a dose of 40 uM/kg by subcutaneous administration		1		organism-based format	Scientific Literature